For research use only. Not for therapeutic Use.
Toralizumab（Cat No.:I042252）is an experimental monoclonal antibody designed to target and inhibit the alpha-4 integrin subunit, a protein involved in the adhesion and migration of immune cells. By blocking this interaction, Toralizumab aims to reduce the inflammatory response associated with autoimmune diseases. It has been investigated for the treatment of conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. The therapy works by preventing immune cells from entering affected tissues, thus reducing inflammation and tissue damage. Research is ongoing to assess its efficacy, safety, and potential for broader therapeutic applications.
| Catalog Number | I042252 |
| CAS Number | 252662-47-8 |
| Purity | ≥95% |
